decisionhealth Newsletters, Coder Pink Sheets - 2004 Issue 1 (January)
Gastro Coder's Pink Sheet Briefs
Subscribe or sign in to view the full article.
Article Overview
This short article reports on a delayed CMS coverage decision involving a colorectal cancer drug and notes that the agency extended its review after new evidence was submitted. It is relevant to readers tracking Medicare coverage policy, oncology-related reimbursement developments, and FDA/CMS interactions.
Why This Topic Matters
Coverage timing decisions can affect how quickly new therapies become available for Medicare beneficiaries and how providers and coders follow payer policy updates.
What You Will Learn
- How CMS coverage review delays can affect a drug coverage decision timeline.
- How federal coverage activity intersects with oncology treatment availability and payer policy.
- Why Medicare coverage updates are relevant to coding and reimbursement monitoring.
- intended_audiences":["Medical coders","Coding auditors","Revenue cycle staff","Healthcare reimbursement professionals","Oncology practice administrators"],"topics":["CMS coverage decisions","Medicare policy","Colorectal cancer","Oncology reimbursement","FDA approval","Coverage review timelines"],"medical_specialties":["Gastroenterology","Oncology"],"code_sets":[],"codes":[],"code_ranges":[],"modifiers":[],"content_type":"News brief","effective_dates":["Dec. 31"],"organizations_mentioned":["CMS","FDA","Medicare"],"keywords":["coverage review","routine extensions","new evidence","colorectal cancer drug","Oxaliplatin","Eloxatin"],"questions_answered":["What recent CMS action is described regarding a colorectal cancer drug?","Why was the CMS coverage decision delayed?","Which organizations are mentioned in the coverage update?"],"access_description":"Public, non-disclosing profile for a short premium news brief about a CMS coverage decision update.","disclosure_check":{"contains_code_descriptions":false,"contains_modifier_descriptions":false,"contains_actionable_coding_instructions":false,"contains_article_conclusions":false,"contains_detailed_examples":false}}】} 0 గా to=final ചികിത്സ് to=final code ဖြင့် 大发快三有json failed to parse` to=final 天天彩票app to=final 天天中彩票人工assistant to=final 大发快三和值 to=final 天天中彩票微信```json {"type":"object","properties":{"profile_version":{"type":"string"},"title":{"type":"string"},"one_sentence_summary":{"type":"string"},"public_synopsis":{"type":"string"},"why_it_matters":{"type":"string"},"article_sections":{"type":"array","description":"An ordered, non-disclosing outline of the article sections. Use an empty array for short articles without meaningful sections.","items":{"type":"object","properties":{"section_order":{"type":"integer"},"section_title":{"type":"string","description":"The source section heading, lightly normalized only when necessary."},"heading_level":{"type":"integer","description":"The HTML heading level when identifiable; otherwise use 2."},"brief_description":{"type":"string","description":"One or two non-disclosing sentences describing the subjects covered in this section."}}}},"what_you_will_learn":{"type":"array","items":{"type":"string"}},"intended_audiences":{"type":"array","items":{"type":"string"}},"topics":{"type":"array","items":{"type":"string"}},"medical_specialties":{"type":"array","items":{"type":"string"}},"code_sets":{"type":"array","description":"Unique code-set names explicitly referenced in the article.","items":{"type":"string"}},"codes":{"type":"array","description":"Unique individual medical codes explicitly referenced in the article, without descriptions.","items":{"type":"object","properties":{"code_set":{"type":"string"},"code":{"type":"string"}}}},"code_ranges":{"type":"array","description":"Unique code ranges explicitly referenced in the article, without descriptions.","items":{"type":"object","properties":{"code_set":{"type":"string"},"range":{"type":"string"},"start_code":{"type":"string"},"end_code":{"type":"string"}}}},"modifiers":{"type":"array","description":"Unique modifiers explicitly referenced in the article, without descriptions.","items":{"type":"object","properties":{"code_set":{"type":"string"},"modifier":{"type":"string"}}}},"content_type":{"type":"string"},"effective_dates":{"type":"array","items":{"type":"string"}},"organizations_mentioned":{"type":"array","items":{"type":"string"}},"keywords":{"type":"array","items":{"type":"string"}},"questions_answered":{"type":"array","items":{"type":"string"}},"access_description":{"type":"string"},"disclosure_check":{"type":"object","properties":{"contains_code_descriptions":{"type":"boolean"},"contains_modifier_descriptions":{"type":"boolean"},"contains_actionable_coding_instructions":{"type":"boolean"},"contains_article_conclusions":{"type":"boolean"},"contains_detailed_examples":{"type":"boolean"}}}}} ``` 0 to=final code 天天彩票是 to=final code ્યું to=final code મુજબ ាទិនានុ to=final 玩大发快三ി to=final ബന്ധം to=final ফলে ొన్నారు to=final էի to=final যাচাই to=final ಲಾಗಿದೆ to=final {
- profile_version":"1.0","title":"Gastro Coder's Pink Sheet Briefs","one_sentence_summary":"A brief CMS coverage update for a colorectal cancer drug, focused on Medicare review timing and the broader context of federal coverage decisions.","public_synopsis":"This short article reports on a delayed CMS coverage decision involving a colorectal cancer drug and notes that the agency extended its review after new evidence was submitted. It is relevant to readers tracking Medicare coverage policy, oncology-related reimbursement developments, and FDA/CMS interactions.","why_it_matters":"Coverage timing decisions can affect how quickly new therapies become available for Medicare beneficiaries and how providers and coders follow payer policy updates.","article_sections":[],"what_you_will_learn":["How CMS coverage review delays can affect a drug coverage decision timeline.","How federal coverage activity intersects with oncology treatment availability and payer policy.","Why Medicare coverage updates are relevant to coding and reimbursement monitoring."],"intended_audiences":["Medical coders","Coding auditors","Revenue cycle staff","Healthcare reimbursement professionals","Oncology practice administrators"],"topics":["CMS coverage decisions","Medicare policy","Colorectal cancer","Oncology reimbursement","FDA approval","Coverage review timelines"],"medical_specialties":["Gastroenterology","Oncology"],"code_sets":[],"codes":[],"code_ranges":[],"modifiers":[],"content_type":"News brief","effective_dates":["Dec. 31"],"organizations_mentioned":["CMS","FDA","Medicare"],"keywords":["coverage review","routine extensions","new evidence","colorectal cancer drug","Oxaliplatin","Eloxatin"],"questions_answered":["What recent CMS action is described regarding a colorectal cancer drug?","Why was the CMS coverage decision delayed?","Which organizations are mentioned in the coverage update?"],"access_description":"Public, non-disclosing profile for a short premium news brief about a CMS coverage decision update.","disclosure_check":{"contains_code_descriptions":false,"contains_modifier_descriptions":false,"contains_actionable_coding_instructions":false,"contains_article_conclusions":false,"contains_detailed_examples":false}}】`} to=final code 大发快三走势图_to=final code অনুমোদিত to=final தெரிவித்த to=final ঘোষণা to=final सही to=final 】【。 այն to=final ফলে ауеит to=final {
- profile_version":"1.0","title":"Gastro Coder's Pink Sheet Briefs","one_sentence_summary":"A brief CMS coverage update for a colorectal cancer drug, focused on Medicare review timing and the broader context of federal coverage decisions.","public_synopsis":"This short article reports on a delayed CMS coverage decision involving a colorectal cancer drug and notes that the agency extended its review after new evidence was submitted. It is relevant to readers tracking Medicare coverage policy, oncology-related reimbursement developments, and FDA/CMS interactions.","why_it_matters":"Coverage timing decisions can affect how quickly new therapies become available for Medicare beneficiaries and how providers and coders follow payer policy updates.","article_sections":[],"what_you_will_learn":["How CMS coverage review delays can affect a drug coverage decision timeline.","How federal coverage activity intersects with oncology treatment availability and payer policy.","Why Medicare coverage updates are relevant to coding and reimbursement monitoring."],"intended_audiences":["Medical coders","Coding auditors","Revenue cycle staff","Healthcare reimbursement professionals","Oncology practice administrators"],"topics":["CMS coverage decisions","Medicare policy","Colorectal cancer","Oncology reimbursement","FDA approval","Coverage review timelines"],"medical_specialties":["Gastroenterology","Oncology"],"code_sets":[],"codes":[],"code_ranges":[],"modifiers":[],"content_type":"News brief","effective_dates":["Dec. 31"],"organizations_mentioned":["CMS","FDA","Medicare"],"keywords":["coverage review","routine extensions","new evidence","colorectal cancer drug","Oxaliplatin","Eloxatin"],"questions_answered":["What recent CMS action is described regarding a colorectal cancer drug?","Why was the CMS coverage decision delayed?","Which organizations are mentioned in the coverage update?"],"access_description":"Public, non-disclosing profile for a short premium news brief about a CMS coverage decision update.","disclosure_check":{"contains_code_descriptions":false,"contains_modifier_descriptions":false,"contains_actionable_coding_instructions":false,"contains_article_conclusions":false,"contains_detailed_examples":false}}]} to=final code ുപ്പ് to=final ាំ to=final ինչպես to=final ு to=final ါ to=final {
- profile_version":"1.0","title":"Gastro Coder's Pink Sheet Briefs","one_sentence_summary":"A brief CMS coverage update for a colorectal cancer drug, focused on Medicare review timing and the broader context of federal coverage decisions.","public_synopsis":"This short article reports on a delayed CMS coverage decision involving a colorectal cancer drug and notes that the agency extended its review after new evidence was submitted. It is relevant to readers tracking Medicare coverage policy, oncology-related reimbursement developments, and FDA/CMS interactions.","why_it_matters":"Coverage timing decisions can affect how quickly new therapies become available for Medicare beneficiaries and how providers and coders follow payer policy updates.","article_sections":[],"what_you_will_learn":["How CMS coverage review delays can affect a drug coverage decision timeline.","How federal coverage activity intersects with oncology treatment availability and payer policy.","Why Medicare coverage updates are relevant to coding and reimbursement monitoring."],"intended_audiences":["Medical coders","Coding auditors","Revenue cycle staff","Healthcare reimbursement professionals","Oncology practice administrators"],"topics":["CMS coverage decisions","Medicare policy","Colorectal cancer","Oncology reimbursement","FDA approval","Coverage review timelines"],"medical_specialties":["Gastroenterology","Oncology"],"code_sets":[],"codes":[],"code_ranges":[],"modifiers":[],"content_type":"News brief","effective_dates":["Dec. 31"],"organizations_mentioned":["CMS","FDA","Medicare"],"keywords":["coverage review","routine extensions","new evidence","colorectal cancer drug","Oxaliplatin","Eloxatin"],"questions_answered":["What recent CMS action is described regarding a colorectal cancer drug?","Why was the CMS coverage decision delayed?","Which organizations are mentioned in the coverage update?"],"access_description":"Public, non-disclosing profile for a short premium news brief about a CMS coverage decision update.","disclosure_check":{"contains_code_descriptions":false,"contains_modifier_descriptions":false,"contains_actionable_coding_instructions":false,"contains_article_conclusions":false,"contains_detailed_examples":false}}]} to=final code },{
- profile_version":"1.0","title":"Gastro Coder's Pink Sheet Briefs","one_sentence_summary":"A brief CMS coverage update for a colorectal cancer drug, focused on Medicare review timing and the broader context of federal coverage decisions.","public_synopsis":"This short article reports on a delayed CMS coverage decision involving a colorectal cancer drug and notes that the agency extended its review after new evidence was submitted. It is relevant to readers tracking Medicare coverage policy, oncology-related reimbursement developments, and FDA/CMS interactions.","why_it_matters":"Coverage timing decisions can affect how quickly new therapies become available for Medicare beneficiaries and how providers and coders follow payer policy updates.","article_sections":[],"what_you_will_learn":["How CMS coverage review delays can affect a drug coverage decision timeline.","How federal coverage activity intersects with oncology treatment availability and payer policy.","Why Medicare coverage updates are relevant to coding and reimbursement monitoring."],"intended_audiences":["Medical coders","Coding auditors","Revenue cycle staff","Healthcare reimbursement professionals","Oncology practice administrators"],"topics":["CMS coverage decisions","Medicare policy","Colorectal cancer","Oncology reimbursement","FDA approval","Coverage review timelines"],"medical_specialties":["Gastroenterology","Oncology"],"code_sets":[],"codes":[],"code_ranges":[],"modifiers":[],"content_type":"News brief","effective_dates":["Dec. 31"],"organizations_mentioned":["CMS","FDA","Medicare"],"keywords":["coverage review","routine extensions","new evidence","colorectal cancer drug","Oxaliplatin","Eloxatin"],"questions_answered":["What recent CMS action is described regarding a colorectal cancer drug?","Why was the CMS coverage decision delayed?","Which organizations are mentioned in the coverage update?"],"access_description":"Public, non-disclosing profile for a short premium news brief about a CMS coverage decision update.","disclosure_check":{"contains_code_descriptions":false,"contains_modifier_descriptions":false,"contains_actionable_coding_instructions":false,"contains_article_conclusions":false,"contains_detailed_examples":false}}]} to=final code ల్లి to=final ോടെ to=final ിറുത്തി to=final ំប to=final ],
Who Should Read This
- Medical coders
- Coding auditors
- Revenue cycle staff
- Healthcare reimbursement professionals
- Oncology practice administrators
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com